Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-14, Stock:JNJ, The news for the past five days is as follows:
2019-03-07: NEWS1: Why News From J&J, Allergan Could Be A Boon For This Biotech Stock.NEWS2: Monthly shots control HIV as well as pills in 2 big studies.NEWS3: Monthly shots control HIV as well as pills in 2 big studies.NEWS4: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS5: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS6: Take Profits Now and Buy Shopify Stock on Its Next Big Dip.NEWS7: Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline.NEWS8: Allergan Rises After FDA Accepts License Applications for Botox Supplements.NEWS9: Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Allergan Recovers After Depression Treatment Candidate Fails Study.NEWS12: Allergan's Depression Candidate Fails in Studies, Stock Down.NEWS13: Allergan Falls After Depression Treatment Candidate Fails Study.NEWS14: 2 Biotech Stocks With Major Incoming Catalysts.NEWS15: 2 Biotech Stocks With Major Incoming Catalysts.NEWS16: 2 Biotech Stocks With Major Incoming Catalysts.
2019-03-08: NEWS1: Can Smart Beta & Factor ETFs Beat the Market?.NEWS2: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS3: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS4: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS5: How to Invest in Woman-Led Companies With ETFs & Stocks.NEWS6: How to Invest in Woman-Led Companies With ETFs & Stocks.NEWS7: Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up.NEWS8: Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up.NEWS9: Major consumer companies make few gains in female representation in board rooms.NEWS10: Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up.NEWS11: Health Care Sector Update for 03/08/2019: SEEL, ACET, ARDX, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 03/08/2019: SEEL, ACET, ARDX, JNJ, PFE, ABT, MRK, AMGN.NEWS13: How to Invest in Woman-Led Companies With ETFs & Stocks.NEWS14: Can Google’s YouTube Still Hit $11.4 Billion in Revenue in 2019?.NEWS15: Cramer: A potential 'blockbuster win' for owners of Johnson & Johnson.NEWS16: Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving.
2019-03-11: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Health Care Sector Update for 03/11/2019: JNJ,ELAN,LLY,AXGT,CRON,CRON.TO.NEWS3: Health Care Sector Update for 03/11/2019: JNJ,ELAN,LLY,AXGT,CRON,CRON.TO.NEWS4: Bayer Submits Application in EU for Prostate Cancer Drug.NEWS5: Bayer Submits Application in EU for Prostate Cancer Drug.NEWS6: Bayer Submits Application in EU for Prostate Cancer Drug.NEWS7: Johnson & Johnson Buys Large Stake in MeiraGTx.NEWS8: The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's.NEWS9: The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's.NEWS10: The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's.NEWS11: Health Care Sector Update for 03/11/2019: AXGT, LCI, HRC, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Health Care Sector Update for 03/11/2019: AXGT, LCI, HRC, JNJ, PFE, MRK, ABT, AMGN.NEWS13: Here's Why Arrowhead Pharmaceuticals Gained 38.2% in February.NEWS14: Here's Why Arrowhead Pharmaceuticals Gained 38.2% in February.NEWS15: Here&apos;s Why Arrowhead Pharmaceuticals Gained 38.2% in February.
2019-03-12: NEWS1: 9 Great Dividend Growth Stocks to Buy.NEWS2: Minerva Neurosciences Inc (NERV) Q4 2018 Earnings Conference Call Transcript.NEWS3: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS4: Britain's Smith & Nephew to buy Osiris in regenerative products push.NEWS5: Home Depot and Johnson & Johnson Are Among Stocks Driving the S&P 500.NEWS6: Health Care Sector Update for 03/12/2019: ZFGN, AKBA, HEXO, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 03/12/2019: ZFGN, AKBA, HEXO, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Why Novartis is a Top 10 SAFE International Dividend Stock (NVS).NEWS9: Why Novartis is a Top 10 SAFE International Dividend Stock (NVS).NEWS10: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS11: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.
2019-03-13: NEWS1: Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study.NEWS2: Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study.NEWS3: 9 Great Dividend Growth Stocks to Buy.NEWS4: 9 Great Dividend Growth Stocks to Buy.NEWS5: Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study.NEWS6: Health Care Sector Update for 03/13/2019: NVCN, CASI, LXRX, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 03/13/2019: NVCN, CASI, LXRX, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2019.NEWS9: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2019.NEWS10: The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie.

Answer: Decrease